Cystic fibrosis therapy: a community ecology perspective
about
Republished: Respiratory microbiota: addressing clinical questions, informing clinical practiceThe pediatric microbiome and the lungFrom in vitro to in vivo Models of Bacterial Biofilm-Related Infections.Real-time metabolomics on living microorganisms using ambient electrospray ionization flow-probe.Breath gas metabolites and bacterial metagenomes from cystic fibrosis airways indicate active pH neutral 2,3-butanedione fermentation.Ecological networking of cystic fibrosis lung infections.The upper respiratory tract as a microbial source for pulmonary infections in cystic fibrosis. Parallels from island biogeography.Contrasted coevolutionary dynamics between a bacterial pathogen and its bacteriophages.Rapid 16S rRNA next-generation sequencing of polymicrobial clinical samples for diagnosis of complex bacterial infections.Respiratory microbiota: addressing clinical questions, informing clinical practice.The lung mycobiome: an emerging field of the human respiratory microbiome.Environment and colonisation sequence are key parameters driving cooperation and competition between Pseudomonas aeruginosa cystic fibrosis strains and oral commensal streptococci.Biogeochemical forces shape the composition and physiology of polymicrobial communities in the cystic fibrosis lung.Microbiome in cystic fibrosis: Shaping polymicrobial interactions for advances in antibiotic therapy.Multidimensional clinical phenotyping of an adult cystic fibrosis patient populationHost-pathogen interplay in the respiratory environment of cystic fibrosis.Pyrosequencing Unveils Cystic Fibrosis Lung Microbiome Differences Associated with a Severe Lung Function DeclineData Mining of Lung Microbiota in Cystic Fibrosis Patients.Modulation of behaviour and virulence of a high alginate expressing Pseudomonas aeruginosa strain from cystic fibrosis by oral commensal bacterium Streptococcus anginosus.A Winogradsky-based culture system shows an association between microbial fermentation and cystic fibrosis exacerbationMetabolomics of pulmonary exacerbations reveals the personalized nature of cystic fibrosis disease.Clinical insights from metagenomic analysis of sputum samples from patients with cystic fibrosis.Modifiable risk factors in periodontitis: at the intersection of aging and disease.How can the cystic fibrosis respiratory microbiome influence our clinical decision-making?Understanding persistent bacterial lung infections: clinical implications informed by the biology of the microbiota and biofilmsThe microbiome of the human lower airways: a next generation sequencing perspective.Discriminating typical and atypical cystic fibrosis-related bacteria by multiplex PNA-FISH.Environmental Burkholderia cenocepacia Strain Enhances Fitness by Serial Passages during Long-Term Chronic Airways Infection in Mice.Fluctuations in airway bacterial communities associated with clinical states and disease stages in cystic fibrosis.Quantitative assessment of individual populations within polymicrobial biofilms.Niche partitioning of a pathogenic microbiome driven by chemical gradients
P2860
Q26797508-10D59875-F0D0-41DA-83CB-1998FED155C5Q26851334-0761B99E-C31A-4678-B4C5-C826695ECA64Q30424697-17974BD2-EE3B-4610-9ABB-9ABA73479ACAQ30564254-20930B36-5102-45F5-9F51-3EE0868E875CQ33647129-E43E8777-B745-4FC7-A6F9-78F7107B2EF4Q33767505-53314FE7-3CD8-4A48-96BC-62DE57089696Q33901596-C769B06D-1F7A-40B4-AB26-4E8D6995CDA7Q34002414-3B440508-D421-41D6-98C8-E39A1956ADE9Q34755870-0E5BBBBF-7381-426A-92B6-D35385E7213FQ34818539-83416894-72E8-407A-B76E-510E462BA5B3Q35082308-CE337DD8-3500-4A08-9AED-5D604C3CC836Q35117696-0B89610C-DA99-4F74-BF84-F1692F57A7C8Q35124468-B284B59F-CEAA-46BE-B3F0-8D295D615DAFQ35124580-5A2A6A0F-38BE-4C44-BD12-4635FEF05DB7Q35230948-FDC4461D-E3A1-4858-9AF1-F566C7E4B2A4Q35799736-F5DAAF88-4745-4880-9EFD-989590708F7DQ36063996-D92D85AA-E1AC-4F4C-8380-46694D70C78AQ36163849-31399C7E-75E9-4B06-8686-10533315CEEEQ36310773-6EF22A29-8123-4781-92CA-138F1A94B8C9Q36756544-5E0349BE-D05E-4433-9AAC-72B30678B4ADQ37191286-33464945-61CC-4ED1-823F-B94E0FACC69CQ37546291-1006A5AF-24EA-40D2-986A-F98E3C6531E3Q38169796-F7D7A2C1-D70E-48C3-8B94-53C5622F511AQ38635041-94113DE0-BD36-4C53-9D6E-2BE4FE089BDFQ39167799-FD714951-6205-417E-AE41-C7DFFF8AF0B7Q46093186-FABA5ED3-CA5C-4254-9FBA-58E53D34D346Q46495945-AF8C0F45-A18B-444B-8350-58712EC52EDEQ47135274-8010D4D2-E9C7-415A-84C0-EDBDDC6A85FBQ55287506-3D190B54-0804-43E1-95E7-DEADDC6A4BE6Q55444974-5582C1C4-04DE-4551-B0E4-93B551D6C0AEQ58376391-AB33AE46-FE8C-49B4-8DA3-856C65399980
P2860
Cystic fibrosis therapy: a community ecology perspective
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Cystic fibrosis therapy: a community ecology perspective
@ast
Cystic fibrosis therapy: a community ecology perspective
@en
Cystic fibrosis therapy: a community ecology perspective
@nl
type
label
Cystic fibrosis therapy: a community ecology perspective
@ast
Cystic fibrosis therapy: a community ecology perspective
@en
Cystic fibrosis therapy: a community ecology perspective
@nl
prefLabel
Cystic fibrosis therapy: a community ecology perspective
@ast
Cystic fibrosis therapy: a community ecology perspective
@en
Cystic fibrosis therapy: a community ecology perspective
@nl
P2093
P2860
P3181
P356
P1476
Cystic fibrosis therapy: a community ecology perspective
@en
P2093
Douglas Conrad
Matthew Haynes
Merry Youle
Paul B. Rainey
Peter Salamon
P2860
P3181
P356
10.1165/RCMB.2012-0059PS
P407
P577
2013-02-01T00:00:00Z